Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide. However, treatment options are limited and often inefficient. The aim of this study was to determine current survival rates for patients diagnosed with HCC and to identify prognostic factors, which will help in choosing ...
Hepatocellular carcinoma (HCC) is a common type of tumor worldwide. The development of systemic treatment of advanced HCC has remained stagnant for a considerable period. During the last years, a series of new treatment regimens based on the combination of immunotherapeutic drugs and targeted drugs ...
PURPOSE: Hepatocellular carcinoma (HCC) is the third leading cause of cancer mortality worldwide. Incidence rates are increasing in the United States. Monitoring incidence, survival, and mortality rates within at-risk populations can facilitate control efforts. METHODS: Age-adjusted incidence trends for...
Liver cancer is the second most lethal cancer worldwide [1]. Liver cancer presents an important public health issue in many countries due to its highly aggressive nature and poor survival rate. Hepatocellular carcinoma (HCC) is the most prevalent form of the primary liver cancer and accounts for...
results from an accumulation of mutations arising out of chronicliver diseases such as hepatitis or cirrhosis.1,2Our knowledge surrounding high-risk groups and the disease’s slow progression, however, point to opportunities for early diagnosis that may drastically improve survival rates for patients....
Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related death, with a 5-year survival rate of <9%18. HCC incidence is closely related to obesity and nonalcoholic fatty liver disease19, and the FAs profile is altered in HCC patients20. The levels of polyunsaturated FAs, ...
The 1-, 3- and 5-year survival rates of the 65 patients were 80.0, 65.0 and 56.0% respectively. Conclusion: TACE treatment can provide a chance of tumor resection for those patients with initially judged unresectable HCCs, and liver resection should be performed when the tumor has shrunk to...
Hepatocellular carcinoma (HCC) cells often invade the portal venous system and subsequently develop into portal vein tumour thrombosis (PVTT). Long noncoding RNAs (lncRNAs) have been associated with HCC, but a comprehensive analysis of their specific ass
Hepatocellular Carcinoma Abstract Hepatocellular carcinoma (HCC) is the fifth most common cancer in the world. Most patients still present late in the course of the disease so that curative therapy is rarely possible. Strategies developed to improve the prognosis include primary prevention, directed at...
The survival rates after recurrence were significantly better in patients with a solitary recurrence, and those treated with transcatheter arterial embolization therapy (TAE). Hepatic resection for patients with functionally well-preserved livers, bearing small tumors correlates with long-term survival. ...